The Oncology Institute, Inc. is a value-based oncology company. The Company manages community-based oncology practices which serve patients at approximately 86 clinic locations across 16 markets and five states throughout the United States. The Company's segment includes patient services, dispensary, and clinical trials & other. Its managed clinics provide a range of medical oncology services, including physician services, in-house infusion, radiation, and programs like outpatient blood product transfusions, along with 24/7 patient support. The Company, through TOI Clinical Research, LLC (TCR), provides and manages clinical trial services and research for the benefit of cancer patients. The Company also provides management services to over 14 clinic locations owned by independent oncology practices. The Company and its affiliated providers have contractual relationships with payors serving a variety of patients, including Medicare Advantage (MA), Medicaid, and commercial patients.
企業コードTOIIW
会社名Oncology Institute Inc
上場日Mar 13, 2020
設立日2019
最高経営責任者「CEO」Dr. Daniel Virnich, M.D.
従業員数- -
証券種類Company Warrant
決算期末- -
本社所在地18000 Studebaker Rd
都市CERRITOS
証券取引所NASDAQ Capital Market Consolidated
国United States of America
郵便番号90703
電話番号15627353226
ウェブサイトhttps://theoncologyinstitute.com/
企業コードTOIIW
上場日Mar 13, 2020
設立日2019
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし